Update: Neumora's IPO went effective March 26, 2025 (NasdaqGS:NMRA).
A PRELIMINARY IPO filing yesterday by Massachusetts-based Neumora Therapeutics lists among company advanta.... Read More
Updated: Jan. 24, 2022: Appello filed for completion of a $13.5MM Series B equity raise.-Ed.
NASHVILLE-BASED Appello Pharmaceuticals Inc. yesterday reported completing its Ser.... Read More
Rep. Shipley
Clean energy 'technology grab for Tennessee': Some State lawmakers are pushing for TNInvestco and State ECD support for two pilot plants that would gene.... Read More
Vanderbilt University Medical Center scientists, allied institutions and industry partners may be stepping-up their assault on pharmaceutical business-as-usual via VU's n.... Read More